brinzolamide

FDA Drug Profile — BRINZOLAMIDE, Azopt

brinzolamide is listed in the FDA National Drug Code directory with 7 NDC codes, marketed under brand names including BRINZOLAMIDE, Azopt. Available dosage forms: suspension/ drops, powder.

Drug details

Generic Name
brinzolamide
Brand Names
BRINZOLAMIDE, Azopt
Application Number
ANDA204884
Sponsor
Bausch & Lomb Incorporated
NDC Codes
7
Dosage Forms
SUSPENSION/ DROPS, POWDER
Routes
OPHTHALMIC
Active Ingredients
BRINZOLAMIDE

Indications and Usage

1 INDICATIONS AND USAGE Brinzolamide ophthalmic suspension is a carbonic anhydrase inhibitor indicated in the treatment of elevated intraocular pressure (IOP) in patients with ocular hypertension or open-angle glaucoma. Brinzolamide ophthalmic suspension is a carbonic anhydrase inhibitor indicated for in the treatment of elevated intraocular pressure (IOP) in patients with ocular hypertension or open-angle glaucoma ( 1 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.